SEARCH

SEARCH BY CITATION

References

  • 1
    Starr, T. K., Jameson, S. C. and Hogquist, K. A., Positive and negative selection of T cells. Annu.Rev.Immunol. 2003. 21: 139176.
  • 2
    Kishimoto, H., Surh, C. D. and Sprent, J., A role for Fas in negative selection of thymocytes in vivo. J.Exp.Med. 1998. 187: 14271438.
  • 3
    Lamhamedi-Cherradi, S. E., Zheng, S. J., Maguschak, K. A., Peschon, J. and Chen, Y. H., Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice. Nat. Immunol. 2003. 4: 255260.
  • 4
    Singer, G. G. and Abbas, A. K., The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994. 1: 365371.
  • 5
    Cretney, E., Uldrich, A. P., Berzins, S. P., Strasser, A., Godfrey, D. I. and Smyth, M. J., Normal thymocyte negative selection in TRAIL-deficient mice. J. Exp. Med. 2003. 198: 491496.
  • 6
    Clayton, L. K., Ghendler, Y., Mizoguchi, E., Patch, R. J., Ocain, T. D., Orth, K., Bhan, A. K. et al., T-cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: the molecular basis of negative selection. EMBO J. 1997. 16: 22822293.
  • 7
    Newton, K., Harris, A. W., Bath, M. L., Smith, K. G. C. and Strasser, A., A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 1998. 17: 706718.
  • 8
    Bouillet, P., Purton, J. F., Godfrey, D. I., Zhang, L.-C., Coultas, L., Puthalakath, H., Pellegrini, M. et al., BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002. 415: 922926.
  • 9
    Walsh, C. M., Wen, B. G., Chinnaiyan, A. M., O'Rourke, K., Dixit, V. M. and Hedrick, S. M., A role for FADD in T cell activation and development. Immunity 1998. 8: 439449.
  • 10
    Salmena, L., Lemmers, B., Hakem, A., Matysiak-Zablocki, E., Murakami, K., Au, P. Y. B., Berry, D. M. et al., Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 2003. 17: 883895.
  • 11
    Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J., Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995. 377: 348351.
  • 12
    Sytwu, H.-K., Liblau, R. L. and McDevitt, H. O., The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996. 5: 1730.
  • 13
    Lohman, B., Razvi, E. S. and Welsh, R. M., T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor–ligand interactions. J. Virol. 1996. 70: 81998203.
  • 14
    Nguyen, L. T., McKall-Faienza, K., Zakarian, A., Speiser, D. E., Mak, T. W. and Ohashi, P. S., TNF receptor 1 (TNFR1) and CD95 are not required for T cell deletion after virus infection but contribute to peptide-induced deletion under limited conditions. Eur. J. Immunol. 2000. 30: 683688.
  • 15
    Hildeman, D. A., Zhu, Y., Mitchell, T. C., Bouillet, P., Strasser, A., Kappler, J. and Marrack, P., Activated T cell death in vivo mediated by proapoptotic Bcl-2 family member bim. Immunity 2002. 16: 759767.
  • 16
    Jaattela, M. and Tschopp, J., Caspase-independent cell dealth in T lymphocytes. Nat. Immunol. 2003. 4: 416423.
  • 17
    Alam, A., Braun, M. Y., Hartgers, F., Lesage, S., Cohen, L., Hugo, P., Denis, F. and Sekaly, R. P., Specific activation of the cysteine protease CPP32 during the negative selection of T cells in the thymus. J. Exp. Med. 1997. 186: 15031512.
  • 18
    Doerfler, P., Forbush, K. A. and Perlmutter, R. M., Caspase enzyme activity is not essential for apoptosis during thymocyte development. J. Immunol. 2000. 164: 40714079.
  • 19
    Sabbagh, L., Kaech, S. M., Bourbonniere, M., Woo, M., Cohen, L. Y., Haddad, E. K., Labrecque, N. et al., The selective increase in caspase-3 expression in effector but not memory T cells allows susceptibility to apoptosis. J. Immunol. 2004. 173: 54255433.
  • 20
    Puga, I., Rao, A. and Macian, F., Targeted cleavage of signaling proteins by caspase 3 inhibits T cell receptor signaling in anergic T cells. Immunity 2008. 29: 193204.
  • 21
    Kuida, K., Zheng, T. S., Na, S., Kuan, C., Yang, D., Karasuyama, H., Rakic, P. and Flavell, R. A., Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996. 384: 368372.
  • 22
    Lakhani, S. A., Masud, A., Kuida, K., Porter, G. A., Jr., Booth, C. J., Mehal, W. Z., Inayat, I. and Flavell, R. A., Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 2006. 311: 847851.
  • 23
    Alam, A., Cohen, L. Y., Aouad, S. and Sekaly, R. P., Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 1999. 190: 18791890.
  • 24
    Kennedy, N. J., Kataoka, T., Tschopp, J. and Budd, R. C., Caspase activation is required for T cell proliferation. J. Exp. Med. 1999. 190: 18911896.
  • 25
    Woo, M., Hakem, R., Soengas, M. S., Duncan, G. S., Shahinian, A., Kagi, D., Hakem, A. et al., Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 1998. 12: 806819.
  • 26
    Pircher, H., Bürki, K., Lang, R., Hengartner, H. and Zinkernagel, R., Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989. 342: 559561.